PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25018C0103Eo14042 - ADD COVID 19 vaccination — Indianapolis Neurosurgical Group, P.C

Indianapolis Neurosurgical Group, P.C holds — across 0 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Jun 30, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

250-Network Contract Office 10 (36C250)

Awarding office

Indianapolis Neurosurgical Group, P.C

Recipient

Jun 30, 2023

PoP end

$1.5M

Obligated

$18.9M

Potential

611310

NAICS

Q523

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Indianapolis Neurosurgical Group, P.C — $90

Contract facts

NONE

Contract number36C25018C0103

Also listed as36C250-18-C-0103

Agency250-Network Contract Office 10 (36C250)

Awarding office250-Network Contract Office 10 (36C250)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentIndianapolis Neurosurgical Group, P.C

CAGE5MHE0

UEID1XLRXZ8FXJ5

NAICS611310

No full NAICS 611310 intel page yet. Browse NAICS intelligence

PSCQ523

Place of performanceINDIANAPOLIS IN

Pricing typeFirm Fixed Price

Extent competedNot Available For Competition

PoP startJul 1, 2018

PoP end (current)Jun 30, 2023

PoP end (w/ options)Jun 30, 2028

Obligated$1.5M

Current value$7.7M

Potential value$18.9M

EO14042 - ADD COVID 19 VACCINATION LANGUAGE IAW FAR CLAUSE 52-223-99. is a federal NONE award for 250-Network Contract Office 10 (36C250) held by Indianapolis Neurosurgical Group, P.C. Estimated value $18.9M ($1.5M obligated). Current period of performance ends Jun 30, 2023 (potential Jun 30, 2028). Last award drew 1 bidder. Place of performance: INDIANAPOLIS IN.

EO14042 - ADD COVID 19 VACCINATION LANGUAGE IAW FAR CLAUSE 52-223-99.

Recompete timing

Public

● Past PoP end (1147 days ago)

Current PoP ended Jun 30, 2023 (1147 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Indianapolis Neurosurgical Group, P.C — — obligated across 0 awards (firm-wide, all agencies).

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25018C0103?

36C25018C0103 (Eo14042 - ADD COVID 19 vaccination) is a 250-Network Contract Office 10 (36C250) award with a potential value of $18.9M, currently held by Indianapolis Neurosurgical Group, P.C. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C250-18-C-0103?

36C250-18-C-0103 is the dashed form of PIID 36C25018C0103 (Eo14042 - ADD COVID 19 vaccination), held by Indianapolis Neurosurgical Group, P.C. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25018C0103?

250-Network Contract Office 10 (36C250) awarded 36C25018C0103 to Indianapolis Neurosurgical Group, P.C (potential $18.9M).

Who is the incumbent on 36C25018C0103?

Indianapolis Neurosurgical Group, P.C is the incumbent with — across 0 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2023.

When does Indianapolis Neurosurgical Group, P.C’s 36C25018C0103 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 30, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 28, 2022